
Overview
Candace DeBerardinis is a certified adult nurse practitioner and an advanced oncology nurse practitioner (AOCNP) in radiation oncology at the Orlando Health Cancer Institute. Her areas of expertise include: Coordinating care for cancer patients undergoing radiation treatment Treatment and management of thyroid cancer Management of radiation treatment and side effects Candace has more than 10 years of experience as an oncology nurse practitioner. She has her radiation certificate and also is certified as an advanced oncology nurse practitioner. She has experience working in medical oncology, bone marrow transplant, benign and malignant hematology, and radiation oncology. She believes in approaching cancer not only with the aim of treating the malignancy and maintaining a patient's life expectancy, but also with the focus of preserving quality of life. Candace believes in treating the whole patient and not just symptoms and disease, as well as the importance of compassion in oncologic care. Candace’s Training Candace received a bachelor’s degree in nursing from the University of Central Florida in Orlando. She earned a Master of Science in nursing (MSN) with certification as an adult nurse practitioner from the University of Cincinnati. About Candace Candace is a certified adult nurse practitioner (ANP-C) by the American Nurses Credentialing Center. She is also certified as an advanced oncology nurse practitioner and has her radiation certificate. She is licensed in Florida as an advanced practice registered nurse. Candace is a founding member of the Advanced Practitioner Society for Hematology and Oncology. Her other professional memberships include the Oncology Nursing Society, American Academy of Nurse Practitioners, Florida Society of Clinical Oncology and Sigma Theta Tau International Honor Society of Nurses. Outside of work, she enjoys being a mother of two boys and cheering for her husband at the racetrack. Her hobbies are classic cars, reading and painting positivity rocks.
Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Biliary Dyskinesia, and Venous Thromboembolism (VTE).
She is actively involved in clinical research, co-authoring 1 peer reviewed article.
Graduate Institution
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 S. Orange Ave., Orlando, FL 32806
AdventHealth Medical Group Radiation Oncology At Central Florida
Ravi Shridhar is a Radiation Oncologist practicing medicine in Altamonte Springs, Florida. Dr. Shridhar is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Anal Cancer, Pancreatic Cancer, Lymphadenectomy, and Pancreatectomy.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Justin Rineer is a board-certified and fellowship-trained radiation oncologist at the Orlando Health Cancer Institute. His specialties include: Lung cancer Head and neck cancer Sarcoma Melanoma Squamous cell carcinoma Basal cell carcinoma Merkel cell carcinoma Thymoma Stereotactic body radiation therapy Proton beam radiation therapy Adaptive radiation therapy Re-irradiation Dr. Rineer and his multidisciplinary team strive to instill confidence and hope in his patients by helping them understand and participate in their treatment plan. Dr. Rineer's Training Dr. Rineer earned his medical degree at State University of New York Downstate in Brooklyn, graduating magna cum laude. He completed a residency in radiation oncology at State University of New York Downstate, where he served as chief resident. He completed a fellowship in advanced radiation oncology at the University of Texas MD Anderson Cancer Center in Houston, where he gained extensive experience in applying advanced medical technologies to lung cancer and other thoracic malignancies. About Dr. Rineer Dr. Rineer is board certified in radiation oncology by the American Board of Radiology. He has presented his original research at top national and international meetings, including the American Society of Radiation Oncology and American Society of Clinical Oncology. His primary research interests include improving outcomes in lung and head and neck cancer by combining multiple treatments. His professional memberships include the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and American Society for Radiation Oncology. Outside of work, he enjoys spending time with family, traveling, cooking, scuba diving, basketball and soccer. He is fluent in English and French. Dr. Rineer is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Prostatectomy. Dr. Rineer is board certified in American Board Of Radiology - Radiation Oncology.
Orlando Health Cancer Institute – Dr. Phillips
Dr. Naren Ramakrishna is a board-certified radiation oncologist with the pediatric brain tumor program at Orlando Health Arnold Palmer Hospital for Children and director of the pediatric and adult proton therapy programs at the Orlando Health Cancer Institute. He cares for children as well as adults, and his specialties include: Brain and spine tumors Proton therapy Brain metastases Meningioma Vestibular schwannoma Pituitary adenoma Astrocytoma Glioblastoma Arteriovenous malformations Trigeminal neuralgia Chordoma Chondrosarcoma Hemangioblastoma Medulloblastoma Ependymoma Dr. Ramakrishna draws on his extensive research background to treat his patients with the most advanced practices. He strives to create supportive, compassionate and empathetic relationships with his patients and their families. Dr. Ramakrishna's Training Dr. Ramakrishna earned his medical degree through the Medical Scientist Training Program at Cornell University's Weill Cornell Medical College in New York. He earned a doctorate in cell biology and genetics from the Weill Cornell Graduate School of Medical Sciences. Dr. Ramakrishna completed a residency in radiation oncology at Johns Hopkins Hospital in Baltimore, where he served as chief resident. He also completed a Koch Research Fellowship in gene therapy and received an American Association for Cancer Research-Glaxo Wellcome Oncology Scholar Award. About Dr. Ramakrishna Dr. Ramakrishna is board certified in radiation oncology by the American Board of Radiology. He served for eight years on the faculty at Harvard Medical School as an instructor in radiation oncology. He also was chief of the radiation oncology department at Dana-Farber/Brigham and Women's Cancer Center and director of the CNS Radiation Oncology Fellowship Program. Dr. Ramakrishna is a principal investigator in a study focused on central nervous system malignancies at Orlando Health Arnold Palmer. He has written numerous book chapters and peer-reviewed manuscripts and has presented his work at national and international conferences. Outside of work, Dr. Ramakrishna is an avid musician and songwriter. He also enjoys kayaking, hiking, rollerblading and biking. Dr. Ramakrishna is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Metastatic Brain Tumor, and Brain Tumor. Dr. Ramakrishna is board certified in Radiation Oncology.
Frequently Asked Questions about Dr. Candace Deberardinis
How do I make an appointment with Dr. Candace Deberardinis?
You can book an appointment with Dr. Candace Deberardinis by calling their office at 321-841-1869. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Candace Deberardinis a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Candace Deberardinis is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Candace Deberardinis specialize in?
While Dr. Candace Deberardinis is a Radiation Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Biliary Dyskinesia, and Venous Thromboembolism (VTE). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Candace Deberardinis accept my insurance?
Dr. Candace Deberardinis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 321-841-1869 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Deberardinis isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Biliary DyskinesiaDr. Deberardinis isExperienced. Learn about Biliary Dyskinesia.
- Venous Thromboembolism (VTE)Dr. Deberardinis isExperienced. Learn about Venous Thromboembolism (VTE).

